Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.53 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2178506 | 0.87 | MAPK1 (0.70) | MAPK1L3MBTL1MTNR1AMTNR1BTSHR | |
| SCHEMBL7642003 | 0.84 | MAPK1 (0.62) | MAPK1L3MBTL1MTNR1AMTNR1BTSHR | |
| SCHEMBL1856039 | 0.81 | L3MBTL1 (0.50) | MAPK1L3MBTL1MTNR1AMTNR1BTSHR | |
| SCHEMBL7641046 | 0.80 | MAPK1 (0.48) | MAPK1L3MBTL1MTNR1AMTNR1BTSHR | |
| SCHEMBL1856638 | 0.79 | PPARA (0.59) | MTNR1AMTNR1BALDH1A1HDAC1HDAC6 | |
| SCHEMBL1206811 | 0.77 | HDAC1 (0.64) | MTNR1AMTNR1BHDAC1HDAC6PPARG | |
| SCHEMBL7642001 | 0.77 | MTNR1A (0.56) | MTNR1AMTNR1BHDAC1HDAC6PPARG | |
| SCHEMBL17274751 | 0.76 | HDAC1 (0.66) | MTNR1AMTNR1BHDAC1HDAC6PPARG | |
| SCHEMBL28820181 | 0.76 | MTNR1A (0.57) | MTNR1AMTNR1BHDAC1HDAC6CHRM2 | |
| SCHEMBL28020307 | 0.76 | MTNR1A (0.57) | MTNR1AMTNR1BHDAC1HDAC6CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203764-A1 | INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES | FASTRACK PHARMACEUTICALS, INC. | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203764-A1 | INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES | VCAM1, AOC3, AOC2 | MAPK1 1725/4885L3MBTL1 3283/4885MTNR1A 3333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.